Bioterrorism Week
Susan Hasty, Publisher
Table of Contents . . . May 10th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Bacterial Toxin - Small molecule inhibitors found active against anthrax lethal factor
Anthrax - Export license granted for biothreat detection assay, GeneXpert System
Anthrax - New type of anthrax vaccine moves into larger-scale trial
Anthrax - Survivors had health problems 1 year after exposure to deadly bacterium
Bioterrorism - Diagnostic algorithm quickly distinguishes anthrax from flu
Biowarfare - Biodefense applications of recombinant polyclonal antibodies reviewed
Finance - Biocatalyst maker receives $100,000 investment
Immunology - ImmuneRegen BioSciences to form bioterrorism advisory board
Research and Development - Successful completion of milestone triggers Protexia drug development
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
